Henry Schein Crescita futura

Future criteri di controllo 3/6

Henry Schein prevede che gli utili e i ricavi cresceranno rispettivamente di 26.7% e 4.5% all'anno. Si prevede che l'EPS crescerà di 21.8% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 15.2% in 3 anni.

Informazioni chiave

26.7%

Tasso di crescita degli utili

21.8%

Tasso di crescita dell'EPS

Healthcare crescita degli utili	20.9%
Tasso di crescita dei ricavi	4.5%
Rendimento futuro del capitale proprio	15.2%
Copertura analitica	Good
Ultimo aggiornamento	08 Nov 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Henry Schein: Another Day, Another Purchase

Nov 20

Henry Schein's (NASDAQ:HSIC) Conservative Accounting Might Explain Soft Earnings

Nov 13

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Apr 14

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Feb 28

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Oct 11

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Sep 23

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Aug 21

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Aug 01

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jul 09

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Jun 09

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

May 21

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

May 01

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Apr 10

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Feb 15

Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled

Jan 28

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jan 10

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Dec 11

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?

Nov 04

Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios

Aug 25

Henry Schein announces $400M increase to stock buyback plan

Aug 18

Previsioni di crescita degli utili e dei ricavi

NasdaqGS:HSIC - Stime future degli analisti e dati finanziari passati (USD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	13,896	617	774	1,024	11
12/31/2025	13,349	559	704	905	12
12/31/2024	12,854	422	642	797	13
9/28/2024	12,499	314	421	612	N/A
6/29/2024	12,487	352	495	692	N/A
3/30/2024	12,451	388	473	670	N/A
12/30/2023	12,339	416	313	500	N/A
9/30/2023	12,693	445	587	786	N/A
7/1/2023	12,598	458	480	653	N/A
4/1/2023	12,528	478	387	536	N/A
12/31/2022	12,647	538	474	602	N/A
9/24/2022	12,607	638	528	625	N/A
6/25/2022	12,718	650	648	738	N/A
3/26/2022	12,655	646	656	740	N/A
12/25/2021	12,401	631	598	710	N/A
9/25/2021	12,236	626	723	783	N/A
6/26/2021	11,898	606	783	833	N/A
3/27/2021	10,615	438	544	583	N/A
12/26/2020	10,119	403	550	599	N/A
9/26/2020	9,622	591	477	542	N/A
6/27/2020	9,291	585	436	512	N/A
3/28/2020	10,054	713	683	766	N/A
12/28/2019	9,986	701	578	654	N/A
9/28/2019	9,789	488	585	655	N/A
6/29/2019	9,636	444	526	597	N/A
3/30/2019	9,504	438	648	722	N/A
12/29/2018	9,418	431	613	685	N/A
9/29/2018	10,263	304	553	629	N/A
6/30/2018	11,069	352	N/A	586	N/A
3/31/2018	11,812	377	N/A	527	N/A
12/30/2017	8,883	293	N/A	546	N/A
9/30/2017	12,264	554	N/A	572	N/A
7/1/2017	11,968	550	N/A	619	N/A
4/1/2017	11,782	534	N/A	668	N/A
12/31/2016	11,572	507	N/A	643	N/A
9/24/2016	11,302	498	N/A	676	N/A
6/25/2016	11,122	492	N/A	605	N/A
3/26/2016	10,879	489	N/A	536	N/A
12/26/2015	10,630	479	N/A	616	N/A
9/26/2015	10,481	482	N/A	563	N/A
6/27/2015	10,419	469	N/A	630	N/A
3/28/2015	10,405	467	N/A	621	N/A
12/27/2014	10,371	466	N/A	593	N/A
9/27/2014	10,196	457	N/A	593	N/A
6/28/2014	9,921	450	N/A	571	N/A
3/29/2014	9,697	442	N/A	647	N/A
12/28/2013	9,561	432	N/A	664	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di HSIC ( 26.7% all'anno) è superiore al tasso di risparmio ( 2.6% ).

Guadagni vs Mercato: Si prevede che gli utili di HSIC ( 26.7% all'anno) cresceranno più rapidamente del mercato US ( 15.4% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di HSIC cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di HSIC ( 4.5% all'anno) crescerà più lentamente rispetto al mercato US ( 8.9% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di HSIC ( 4.5% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di HSIC sarà basso tra 3 anni ( 15.2 %).

Henry Schein Crescita futura

Future criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Henry Schein, Inc. Updates Earnings Guidance for the Full Year 2024

Price target decreased by 7.7% to US$73.27

Consensus EPS estimates fall by 12%

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Henry Schein, Inc. Provides Earnings Guidance for 2023

Recent updates

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire Acentus.

Henry Schein: Another Day, Another Purchase

Ananym Capital Management Pushes for Changes at Henry Schein

Ananym Capital Management Pushes for Changes at Henry Schein

Henry Schein's (NASDAQ:HSIC) Conservative Accounting Might Explain Soft Earnings

New minor risk - Earnings quality

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Updates Earnings Guidance for the Full Year 2024

Is Now An Opportune Moment To Examine Henry Schein, Inc. (NASDAQ:HSIC)?

Henry Schein, Inc. to Report Q3, 2024 Results on Nov 05, 2024

Henry Schein, Inc.'s (NASDAQ:HSIC) Popularity With Investors Is Clear

Henry Schein, Inc.(NasdaqGS:HSIC) dropped from FTSE All-World Index (USD)

Price target decreased by 7.7% to US$73.27

Insider recently sold US$1.5m worth of stock

Insider notifies of intention to sell stock

Henry Schein (NASDAQ:HSIC) Will Be Hoping To Turn Its Returns On Capital Around

Consensus EPS estimates fall by 12%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Time To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

Henry Schein, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Market Participants Recognise Henry Schein, Inc.'s (NASDAQ:HSIC) Earnings

Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight

Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority interest in TriMed, Inc.

Insider recently sold US$478k worth of stock

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Full year 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc.

Henry Schein Appoints Carole T. Faig as New Independent Director

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. announced delayed 10-Q filing

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority stake in Shield HealthCare, Inc.

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire a majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired a majority stake in Large Practice Sales LLC.

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Insider recently sold US$835k worth of stock

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Executive Vice Chairman & President notifies of intention to sell stock

Executive VP & COO notifies of intention to sell stock

Executive VP recently sold US$1.9m worth of stock

Executive VP notifies of intention to sell stock

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) agreed to acquire SIN - Sistema de Implante Nacional S.A. from Southern Cross Group.

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly